Tauriga Sciences Inc. Approved to Renew its Status as a Vendor to the National Association of College Stores
Tauriga Sciences, Inc. (OTCQB: TAUG) has renewed its status as an Affiliate Vendor to the National Association of College Stores (NACS) for 2022. This partnership provides access to a $10 billion collegiate retail market, which the company believes offers lucrative business opportunities. Additionally, Tauriga will have a corporate Exhibitor Booth at the NACS Campus Market Expo 2022 from February 26 to March 2 in Louisville, Kentucky. The company specializes in CBD and CBG edibles, including Tauri-Gum™ products, and is engaged in pharmaceutical development targeting chemotherapy-related nausea.
- Renewed Affiliate Vendor status with NACS through 2022 enhances market access.
- Participation in NACS Campus Market Expo 2022 opens opportunities for increased visibility and customer acquisition.
- Engagement in the lucrative collegiate retail market estimated at $10 billion.
- None.
NEW YORK, NY, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The Company Will Operate Corporate Exhibitor Booth at NACS Campus Market 2022 Tradeshow
via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has been approved to renew its status as an Affiliate Vendor (“Vendor”) to the National Association of College Stores (“NACS”). This renewal is valid through Calendar Year 2022. As a Vendor to the NACS, the Company is part of the most comprehensive group of College Campus Retailers – working to provide the best services and selections to college students across the United States of America. Additionally, the Company believes that the Collegiate Retail Market (i.e. campus bookstores) represents a potentially lucrative business opportunity during Calendar Year 2022 and beyond.
The National Association of College Stores is the professional trade association of the
In addition, Tauriga Sciences will be operating a corporate Exhibitor Booth at the NACS Campus Market Expo 2022 Tradeshow (the “Event”). This Event will take place in Louisville, Kentucky between the dates: February 26th– March 2nd, 2022.
Link to Event: https://www.camex.org
TAURIGA SCIENCES INC.
NACS AFFILIATE VENDOR I.D. #: 113921
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (DELTA 8 THC Infused Tauri-Gum™ Flavor: Evergreen Mint), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden Raspberry). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.
The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
FAQ
What is Tauriga Sciences' stock symbol?
What event will Tauriga Sciences exhibit at in 2022?
What is the significance of the NACS for Tauriga Sciences?
How long is Tauriga Sciences' renewal with NACS valid?
What products does Tauriga Sciences focus on?
